626 related articles for article (PubMed ID: 17766128)
1. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Hegedus J; Putman CT; Gordon T
Neurobiol Dis; 2007 Nov; 28(2):154-64. PubMed ID: 17766128
[TBL] [Abstract][Full Text] [Related]
2. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
[TBL] [Abstract][Full Text] [Related]
3. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Sharp PS; Dick JR; Greensmith L
Neuroscience; 2005; 130(4):897-910. PubMed ID: 15652988
[TBL] [Abstract][Full Text] [Related]
4. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis.
Hegedus J; Putman CT; Tyreman N; Gordon T
J Physiol; 2008 Jul; 586(14):3337-51. PubMed ID: 18467368
[TBL] [Abstract][Full Text] [Related]
5. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve-muscle contacts.
Sharp PS; Tyreman N; Jones KE; Gordon T
Neurobiol Dis; 2018 May; 113():33-44. PubMed ID: 29409912
[TBL] [Abstract][Full Text] [Related]
6. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1
Harrison JM; Rafuse VF
Neurobiol Dis; 2020 Nov; 145():105052. PubMed ID: 32827689
[TBL] [Abstract][Full Text] [Related]
7. Progressive motor unit loss in the G93A mouse model of amyotrophic lateral sclerosis is unaffected by gender.
Hegedus J; Putman CT; Gordon T
Muscle Nerve; 2009 Mar; 39(3):318-27. PubMed ID: 19208415
[TBL] [Abstract][Full Text] [Related]
8. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
9. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; MusarĂ² A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
10. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF.
Pun S; Santos AF; Saxena S; Xu L; Caroni P
Nat Neurosci; 2006 Mar; 9(3):408-19. PubMed ID: 16474388
[TBL] [Abstract][Full Text] [Related]
11. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
12. Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice.
David G; Nguyen K; Barrett EF
Exp Neurol; 2007 Mar; 204(1):411-20. PubMed ID: 17292357
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
14. Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice.
Tallon C; Russell KA; Sakhalkar S; Andrapallayal N; Farah MH
Neuroscience; 2016 Jan; 312():179-89. PubMed ID: 26592719
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment.
Derave W; Van Den Bosch L; Lemmens G; Eijnde BO; Robberecht W; Hespel P
Neurobiol Dis; 2003 Aug; 13(3):264-72. PubMed ID: 12901841
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a coinducer of the heat shock response delays muscle denervation in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Kalmar B; Edet-Amana E; Greensmith L
Amyotroph Lateral Scler; 2012 Jun; 13(4):378-92. PubMed ID: 22591194
[TBL] [Abstract][Full Text] [Related]
17. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
18. Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice.
Yoo YE; Ko CP
PLoS One; 2012; 7(5):e37258. PubMed ID: 22606355
[TBL] [Abstract][Full Text] [Related]
19. Early detection of denervated muscle fibers in hindlimb muscles after sciatic nerve transection in wild type mice and in the G93A mouse model of amyotrophic lateral sclerosis.
Gordon T; Ly V; Hegedus J; Tyreman N
Neurol Res; 2009 Feb; 31(1):28-42. PubMed ID: 18768111
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
Dupuis L; Loeffler JP
Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]